Industry Analysis

The  Global Tracheostomy Products Market  is estimated to be valued at USD 203,080.97 Thousand by 2024 and is projected to register a CAGR of 3.50% during the forecast period. Tracheostomy is a surgical procedure to treat breathing-related diseases where a stoma (hole) is created via the neck into the trachea (windpipe). Generally, tracheostomy is performed when the route of breathing is blocked or impaired, to provide an air passage to help to breathe. Tracheostomy is needed when the long-term use of ventilators is required for artificial breathing, but in some instances, emergency tracheotomy is also performed. There are generally two types of tracheostomies, namely, surgical tracheostomy and minimally invasive tracheostomy. In both types, the stoma can be surgically closed once the tracheostomy is no longer needed. The high prevalence of respiratory disorders and favorable reimbursement policy are anticipated to drive the market growth. However, a product recall is projecte...

Surgical sutures are used for enclosing body incisions to prevent infections thus healing the wound quickly; these are referred as stiches in lay man terms.  Middle East and Africa surgical sutures market  has been growing at a moderate rate due to factors such as rising incidences of accidents which leads to greater use of sutures, growing popularity of cosmetic surgeries and development of advanced sutures such as film coated sutures. The market’s constraints includes increasing preference for minimally invasive surgical procedures and the presence of alternative wound care products; these are key factors which are expected to restrain the growth of this market. The current market highlights include the dominance of absorbable sutures over the non-absorbable. The absorbable segment accounts for the largest market share and is also a fast growing segment as compared to non- absorbable. The demand of synthetic sutures is growing faster as compared to natural sutures. The devel...

The global  chronic diseases management market  is expected to grow at a CAGR of 17.5% during the forecast period. There are wide market for chronic diseases management globally owing to its application in various field such as asthma, cancer, cardiovascular, diabetes, stroke and many more. Increasing prevalence of chronic disease globally considering the major factor which lead the growth of chronic diseases management market globally. According to a Cancer research U.K, in 2014, around 356,860 people were diagnosed with cancer. Report suggest that it incident of cancer are rising rapidly in last few years and expected to grow quickly in the coming future owing to unhealthy diets, high rate of smoke and alcohol consumption. One of the primary factors anticipated to fuel the rise and demand for  chronic disease treatment  is the global increase in the prevalence of chronic diseases such as COPD, asthma, cancer, diabetes, stroke, or musculoskeletal problems. Increasin...

The global market for orthopedic trauma devices is projected to register CAGR of 8% during the forecast period as predicted by Market Research Future (MRFR). Increasing number of trauma associated with road accidents and other causes is expected to fuel the market growth. Rising geriatric population also aides the growth of the  orthopedic trauma devices marke t, as people in this age group are highly prone to bone fractures resulting from fall injury and other orthopedic complications. It has also been observed that an increasing number of people are getting interested in some form of sport, owing to increasing awareness about one’s health. This has resulted in an accelerated number of injuries associated with sport, thus having a knock-on effect on the global market size. Moreover, a handful of companies are involved in the development and marketing of orthopedic trauma devices, thereby leading to the market to evolve with growth opportunity. But the market is not witho...

The global  hematuria treatment market  is accruing rapidly mainly due to the increasing number of bladder or kidney stones; kidney disease; urinary tract infection, cystitis (bladder infection), or pyelonephritis (kidney infection); cancers of the urinary tract (kidney, bladder, prostate); trauma, injury, or urinary tract instrumentation; rigorous exercise; benign prostatic hyperplasia; and blood thinners for such as Antithrombotic medications. In addition to the chronic diseases, infection or diseases are too impacting the market growth positively. At the same time, there are various treatments and novel medications available for hematuria management which are pushing up the market on the global platform. Acknowledging the colossal growth, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global hematuria treatment market will grow exponentially by 2023 accruing at a striking CAGR during the forecast per...

Market Research Future (MRFR) in their report on the global  capnography market  predicted a rise by 19.5% CAGR over the review period (2018-2027). The market is expected to record a substantial market valuation by the end of 2027. Capnography is the process to measure CO2 presence in the respiratory gases. It is mostly used during anesthesia in intensive care. The measurement is shown through a graph which is known as capnogram. The measurement of the CO2 in the arterial blood is essential in conditions such as congenital heart disease. It works by understanding the CO2 absorption through infrared radiation. Its analysis is fast, and accuracy is highly esteemed. Among other situations, capnography works well with pulmonary perfusion, alveolar ventilation, respiratory patterns, and elimination of CO2 from breathing circuit and ventilator during anesthesia. MRFR in their report on the market makes an impactful analysis of the segments, along with their volume-wise and value-wis...

Acknowledging the traction, the market is garnering today; Market Research Future (MRFR) in its recently published study report asserts that the value of global  circulating tumor cell market  will be escalated to USD 28,300 Mn. by 2023 from USD 9,393.1 Mn. (in 2017). The CTC market will achieve this phenomenal growth registering an equally remarkable CAGR during the forecast period. Circulating tumor cell (CTC) is a rare cancer cell that is released into the bloodstream to gain the potential to provide vital information about a person’s specific cancer. However, the clear correlation established between the number of these tumor cells and disease progression that could deliver a promise of clinical application of CTCs as a 'liquid biopsy' has not been so fruitful because of the rarity of these cells leading to posing challenges for detection and analysis using the current molecular biology techniques. However, knowing the significance of CTC in cancer treatments, off late, ma...

Acknowledging the heightened accruals this market is witnessing currently, Market Research Future (MRFR), in its recently published study report, asserts that the global  Media Sera and Reagents- Cell culture market  will register 7.2% CAGR during forecast period. Media Sera and Reagents are products used in Cell culture environment. Over the last few years, the market of these products is growing pervasively majorly due to the increasing demand for biotechnological and biopharmaceuticals products in the pharmaceutical labs for the development of new drugs. Increasing prevalence of chronic diseases is prompting the need for effective medicines and treatment methods. This, as a result, escalates the market on the furthered heights on the global platform. Discoveries of new medicines demand extensive research and development activities, further presaging substantial amounts of investments and efforts required for the same. Hence, private and public entities are making substantia...

The global  brachytherapy market  is expected to exhibit a solid 10.9% CAGR over the forecast period, according to a new market research report from Market Research Future (MRFR). The report presents a detailed analysis of the global brachytherapy market’s projected growth rate and valuation on the basis of the market’s historical performance figures and an analysis of the key trends moving the market. Brachytherapy is a type of radiation therapy performed with the source of radiation being placed near the site of treatment. The growing demand for cancer treatment is likely to be the major driving factor for the global brachytherapy market over the forecast period. The growing prevalence of various types of cancers has become a major concern for healthcare organizations around the world and the field of cancer research has gained considerable funding in the last few years from governments and private agencies alike, leading to growing demand for effective treatment methods suc...

As per the latest study published by Market Research Future (MRFR), the Asia Pacific  orthopedic biomaterial market  is poised to strike a CAGR of 12.6% during the forecast period 2017 to 2023. Biomaterials are extensively used for manufacturing implants as they do not evoke immunological reactions. The growth of the orthopedic branch of medicine coupled with rising demand for biomaterials for implants is likely to drive the growth of the Asia Pacific orthopedic biomaterial market in the upcoming years. The advancements in the medical science over the years has catalyzed the adoption of biomaterials for implants and surgeries. The trend is projected to perpetuate during the projection period. Furthermore, the extensive use of biomaterials for the treatment of internal fractures is another factor responsible for driving the expansion of the Asia Pacific orthopedic biomaterial market. The rising demand for knee and hip replacements coupled with increasing medical emergencies and...

The global  cervical fusion market  consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas region accounted for the largest market share for the global cervical fusion market owing to the growing occurrence of spinal deformities among the older population and the increasing awareness among the masses for preventive care treatments to avoid spinal deformities. The European region accounted for the second largest market owing to the factors such as the rising geriatric population and the increasing prevalence of rheumatoid and osteoarthritis. In the recent years, the growth of cervical fusion devices had confronted many challenges such as stringent regulatory norms, and low adoption of these techniques. Moreover, the Asia Pacific region is expected to witness a fast growth over the forecast period for the global cervical fusion market. The Middle Eastern region is expected to develop at a steady pace owing to the factors suc...